Clinical validation of full HR-HPV genotyping HPV Selfy assay according to the international guidelines for HPV test requirements for cervical cancer screening on clinician-collected and self-collected samples

Will COVID-19 Be the Tipping Point for Primary HPV Self-sampling?

(2021) Anita W.W. Lim   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Commercially available molecular tests for human papillomaviruses: a global overview

(2020) M. Poljak et al.   CLINICAL MICROBIOLOGY AND INFECTION

Clinical performance of Anyplex II HPV28 by human papillomavirus type and viral load in a referral population

(2019) Ingrid Baasland et al.   PLoS One

Preventing cervical cancer using HPV self-sampling: direct mailing of test-kits increases screening participation more than timely opt-in procedures - a randomized controlled trial

(2018) Mette Tranberg et al.   BMC CANCER

Concordant testing results between various human papillomavirus assays in primary cervical cancer screening: systematic review

(2018) L. de Thurah et al.   CLINICAL MICROBIOLOGY AND INFECTION

VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples

(2018) M. Arbyn et al.   JOURNAL OF CLINICAL VIROLOGY

Cervical Cancer Screening Programs in Europe: The Transition Towards HPV Vaccination and Population-Based HPV Testing

(2018) Andreas Chrysostomou et al.   Viruses-Basel

Self-sampling for human papillomavirus DNA detection: a preliminary study of compliance and feasibility in BOLIVIA

(2017) Pedro Surriabre et al.   BMC Womens Health

Cross-reactivity profiles of hybrid capture II, cobas, and APTIMA human papillomavirus assays: split-sample study

(2016) Sarah Preisler et al.   BMC CANCER

Self-sampling in cervical cancer screening: comparison of a brush-based and a lavage-based cervicovaginal self-sampling device

(2016) Liisa Karjalainen et al.   BMC CANCER

Commercially available molecular tests for human papillomaviruses (HPV): 2015 update

(2016) Mario Poljak et al.   JOURNAL OF CLINICAL VIROLOGY

The DNA load of six high-risk human papillomavirus types and its association with cervical lesions

(2015) Luisa Del Río-Ospina et al.   BMC CANCER

Women’s experience with home-based self-sampling for human papillomavirus testing

(2015) Farhana Sultana et al.   BMC CANCER

Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study

(2015) Ditte Møller Ejegod et al.   BMC CANCER

Self-sampling to increase participation in cervical cancer screening: an RCT comparing home mailing, distribution in pharmacies and recall letter

(2015) P Giorgi Rossi et al.   BRITISH JOURNAL OF CANCER

Rationale and design of the iPap trial: a randomized controlled trial of home-based HPV self-sampling for improving participation in cervical screening by never- and under-screened women in Australia

(2014) Farhana Sultana et al.   BMC CANCER

Comparison of HPV genotypes and viral load between different sites of genital tract: The significance for cervical cancer screening

(2014) Shao-Kai Zhang et al.   Cancer Epidemiology

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening

(2014) HC Kitchener et al.   HEALTH TECHNOLOGY ASSESSMENT

HPV self-sampling as primary screening test in sub-Saharan Africa: Implication for a triaging strategy

(2014) Sarah Untiet et al.   INTERNATIONAL JOURNAL OF CANCER

Accuracy of human papillomavirus testing on self-collected versus clinician-collected samples: a meta-analysis

(2014) Marc Arbyn et al.   LANCET ONCOLOGY

Disagreement between Human Papillomavirus Assays: An Unexpected Challenge for the Choice of an Assay in Primary Cervical Screening

(2014) Matejka Rebolj et al.   PLoS One

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial

(2014) K. M. Elfstrom et al.   BMJ-British Medical Journal

Comparing the performance of six human papillomavirus tests in a screening population

(2013) J Cuzick et al.   BRITISH JOURNAL OF CANCER

Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study

(2013) Arundhati Rao et al.   JOURNAL OF CLINICAL VIROLOGY

Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

(2013) Guglielmo Ronco et al.   LANCET

Prospective Study of HPV16 Viral Load and Risk of In Situ and Invasive Squamous Cervical Cancer

(2012) K. Sundstrom et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

European Guidelines for Quality Assurance in Cervical Cancer Screening. Second Edition--Summary Document

(2010) M. Arbyn et al.   ANNALS OF ONCOLOGY

The effect of self-sampled HPV testing on participation to cervical cancer screening in Italy: a randomised controlled trial (ISRCTN96071600)

(2010) P Giorgi Rossi et al.   BRITISH JOURNAL OF CANCER

Measuring agreement of administrative data with chart data using prevalence unadjusted and adjusted kappa

(2009) Guanmin Chen et al.   BMC Medical Research Methodology

The challenges of organising cervical screening programmes in the 15 old member states of the European Union

(2009) Marc Arbyn et al.   EUROPEAN JOURNAL OF CANCER

Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older

(2008) Chris J.L.M. Meijer et al.   INTERNATIONAL JOURNAL OF CANCER

Coverage of Cervical Cancer Screening in 57 Countries: Low Average Levels and Large Inequalities

(2008) Emmanuela Gakidou et al.   PLOS MEDICINE